Roche Holding said it is proceeding with phase 3 development of its Parkinson's disease antibody prasinezumab. The Swiss pharmaceutical company said Monday that the decision follows data from recent ...

Roche entered into a Licensing, Development, and Commercialisation agreement with Prothena in December 2013 to develop and ...

A schematic diagram of the development of next-generation RNA gene editing technology using induction evolution The Catholic ...

The Cincinnati Ballet, in collaboration with Parkinson Support and Wellness, hosted an event at the Margaret and Michael ...

A surprising new study from Rutgers Health has found that people who took penicillin antibiotics multiple times had a slightly lower risk of developing Parkinson’s disease. While the effect is modest, ...

In the often tumultuous world of Hollywood, where relationships frequently falter under the spotlight, Michael J. Fox and ...